Data portfolio

Discover our oncology-focused data projects available for licensing or collaboration.

Image of a scientist leaning over, looking closely at a computer screen.

Our datasets

We hold exclusive rights to a wide variety of oncology-focused projects available for licensing or collaboration. 

All data partnerships are governed by our patient-centric guidelines for safe, secure, and transparent collaborations and are subject to review by our patient involvement group. 

View our guiding principles for data partnerships 

Current dataset portfolio

NameCancer indicationData typeNumber of patientsCohort description
OPTIMAM mammography datasetBreast
  • Mammography images (2D and 3D)
  • Annotated regions of interest
  • Associated clinical information
  • More than 175,000
Mammograms collected from the national breast screening programme
S:CORT                                                                   Colorectal
  • Genomics
  • Transcriptomics
  • Digital pathology images
  • Epigenetics
  • Clinical outcomes
  • More than 1,700
Mostly late-stage CRC patients recruited to 8 clinical trials testing radiotherapy, chemotherapy and targeted drugs
Digital pathology images from the BEST 2/3 trials                           Oesophageal cancer and pre-cancerous states
  • Digital pathology images
  • Associated ground truth clinical information
  • More than 3,300
Digital pathology images collated from the BEST 2 and 3 trials that looked to test the clinical suitability of the EndoSign clinical sampling technique

 

Data assets coming soon

Cancer indicationData descriptionEstimated availability
Non-small cell lung cancer
  • Real world clinical outcome data for >700 NSCLC patients treated with immune checkpoint inhibitors
3-6 months
Breast
  • Imaging Mass Cytometry
  • Associated clinical outcomes (response to immune checkpoint inhibitors treatment)
6 months

 

Interested in a specific dataset?

Get in touch with us to discuss access to our datasets. Alternatively, if you have specific data needs for your project that aren't listed here, get in touch and we can discuss opportunities arising from our early-stage pipeline.

Contact us